Medicare Enrolled

Dr. Hareesha Vemuganti, M.D

Internal Medicine · Cedar Park, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1401 MEDICAL PKWY STE 200, Cedar Park, TX 78613
5122606050
In practice since 2009 (16 years)
NPI: 1861623340 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vemuganti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vemuganti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vemuganti

Dr. Hareesha Vemuganti is an internal medicine in Cedar Park, TX, with 16 years in practice. Based on federal Medicare data, Dr. Vemuganti performed 46,649 Medicare services across 1,648 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vemuganti received a total of $1,681 from 32 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vemuganti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 1% volume in TX$ $1,681 industry payments

Medicare Practice Summary

Medicare Utilization ↗
46,649
Medicare services
Top 1% in TX for internal medicine
1,648
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,916 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron sucrose injection (Venofer)12,800$0$2
Pembrolizumab injection (Keytruda)11,700$43$137
Anti-nausea injection (fosaprepitant)6,600$0$5
Darbepoetin injection (Aranesp) for anemia6,085$2$20
Contrast dye for imaging (iodine-based)2,300$0$3
Dexamethasone injection (steroid)1,414$0$1
Blood draw (venipuncture)811$8$20
Complete blood count (CBC) with differential748$8$36
Injection, fluorouracil, 500 mg618$2$13
Anti-nausea injection (Aloxi/palonosetron)600$1$114
Office visit, established patient (30-39 min)450$91$368
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less216$22$157
Administration of chemotherapy into vein, 1 hour or less207$96$707
Immunoglobulin level test177$9$56
Office visit, established patient (20-29 min)139$55$250
Folic acid level test113$14$73
Vitamin B-12 level test111$15$76
Red blood count, automated test105$4$23
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less100$48$313
Injection, zoledronic acid, 1 mg98$6$431
Measurement of immunoglobulin light chains96$17$60
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session93$272$2,762
Microscopic examination for white blood cells with manual cell count82$4$22
Complete blood count (CBC), automated82$6$34
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-378$20$128
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l77$123$500
Carcinoembryonic antigen (cea) protein level64$18$99
Administration of chemotherapy into vein, each additional hour61$20$161
Drug injection, under skin or into muscle55$10$96
Reticulated (young) platelet measurement50$35$143
Infusion, normal saline solution , 1000 cc50$2$19
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev49$178$700
Injection of additional new drug or substance into vein45$11$108
Injection, diphenhydramine hcl, up to 50 mg39$1$7
Administration of additional new drug or substance into vein, 1 hour or less38$49$344
Infusion into a vein for hydration, each additional hour34$9$75
Protein measurement, serum33$11$99
Immunologic analysis technique on serum33$29$108
Immunologic analysis technique on serum (immunofixation)33$22$160
Office visit, established patient, complex (40-54 min)28$132$496
Thyroid stimulating hormone (TSH) test27$16$80
New patient office visit, complex (60-74 min)23$158$709
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour20$16$100
Ct scan of chest with contrast19$40$821
Infusion into a vein for hydration, 31-60 minutes19$23$256
CT scan of abdomen and pelvis with contrast16$145$1,067
New patient office visit (45-59 min)13$114$565
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
91.5% medium
7.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,681
Total received (2021-2024)
Avg $420/year across 4 years
Top 32% in TX for internal medicine
32
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,251 (74.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$430 (25.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$904
2023
$461
2022
$286
2021
$30

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$299
Novartis Pharmaceuticals Corporation
$179
Karyopharm Therapeutics Inc.
$124
Lilly USA, LLC
$122
Medtronic, Inc.
$96
Apellis Pharmaceuticals, Inc.
$84
GlaxoSmithKline, LLC.
$84
Merck Sharp & Dohme LLC
$69
Janssen Biotech, Inc.
$52
GENZYME CORPORATION
$48
Seagen Inc.
$46
AstraZeneca Pharmaceuticals LP
$42
Celgene Corporation
$40
Gilead Sciences, Inc.
$33
TAIHO ONCOLOGY, INC.
$25
ABBVIE INC.
$25
E.R. Squibb & Sons, L.L.C.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
Eisai Inc.
$22
Mirati Therapeutics, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
BeiGene USA, Inc.
$20
PFIZER INC.
$20
Secura Bio, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$19
Incyte Corporation
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Jazz Pharmaceuticals Inc.
$18
Exelixis Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
EMD Serono, Inc.
$16
Amgen Inc.
$15
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · BAVENCIO · CABOMETYX · COPIKTRA · DARZALEX · ENDO GIA ULTRA · Empaveli · Fabhalta · GILOTRIF · IBRANCE · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · OJJAARA · OPDUALAG · PADCEV · PREVYMIS · PROMACTA · Padcev · Pomalyst · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TEVIMBRA · VENCLEXTA · VPRIV · Vyloy · XPOVIO · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for a internal medicine in Cedar Park?
Compare internal medicines in the Cedar Park area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
880
Per 100K population
136.7
County median income
$108,309
Nearest hospital
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vemuganti is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Vemuganti experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Vemuganti performed 12,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vemuganti receive payments from pharmaceutical companies?
Yes. Dr. Vemuganti received a total of $1,681 from 32 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vemuganti's costs compare to other internal medicines in Cedar Park?
Dr. Vemuganti's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vemuganti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →